These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 27297488

  • 1. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
    Li W, Obregón-Henao A, Wallach JB, North EJ, Lee RE, Gonzalez-Juarrero M, Schnappinger D, Jackson M.
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5198-207. PubMed ID: 27297488
    [Abstract] [Full Text] [Related]

  • 2. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT, Haiderer ER, Coulson GB, Conner KN, Ellsworth E, Chen C, Alvarez-Cabrera N, Li W, Jackson M, Dick T, Abramovitch RB.
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [Abstract] [Full Text] [Related]

  • 3. HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter.
    Zheng H, Williams JT, Coulson GB, Haiderer ER, Abramovitch RB.
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661875
    [Abstract] [Full Text] [Related]

  • 4. 1H-Benzo[d]Imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosis.
    Korycka-Machała M, Viljoen A, Pawełczyk J, Borówka P, Dziadek B, Gobis K, Brzostek A, Kawka M, Blaise M, Strapagiel D, Kremer L, Dziadek J.
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
    [Abstract] [Full Text] [Related]

  • 5. A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3.
    Dupont C, Chen Y, Xu Z, Roquet-Banères F, Blaise M, Witt AK, Dubar F, Biot C, Guérardel Y, Maurer FP, Chng SS, Kremer L.
    J Biol Chem; 2019 Nov 15; 294(46):17512-17523. PubMed ID: 31562241
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro.
    Li W, Sanchez-Hidalgo A, Jones V, de Moura VC, North EJ, Jackson M.
    Antimicrob Agents Chemother; 2017 Apr 15; 61(4):. PubMed ID: 28115355
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J, Yue J, Wu J, Luo R, Hu Z, Li J, Bai Y, Tang Z, Xian Q, Zhang X, Wang H.
    Pharmacology; 2010 Apr 15; 85(6):365-71. PubMed ID: 20530976
    [Abstract] [Full Text] [Related]

  • 10. Allosteric coupling of substrate binding and proton translocation in MmpL3 transporter from Mycobacterium tuberculosis.
    Babii S, Li W, Yang L, Grzegorzewicz AE, Jackson M, Gumbart JC, Zgurskaya HI.
    mBio; 2024 Oct 16; 15(10):e0218324. PubMed ID: 39212407
    [Abstract] [Full Text] [Related]

  • 11. Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.
    Kayigire XA, Friedrich SO, van der Merwe L, Diacon AH.
    Antimicrob Agents Chemother; 2017 Apr 16; 61(4):. PubMed ID: 28167550
    [Abstract] [Full Text] [Related]

  • 12. Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.
    Belardinelli JM, Yazidi A, Yang L, Fabre L, Li W, Jacques B, Angala SK, Rouiller I, Zgurskaya HI, Sygusch J, Jackson M.
    ACS Infect Dis; 2016 Oct 14; 2(10):702-713. PubMed ID: 27737557
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
    Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, Sharma VD.
    Microb Drug Resist; 2010 Mar 14; 16(1):21-8. PubMed ID: 20001742
    [Abstract] [Full Text] [Related]

  • 15. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
    McNeil MB, O'Malley T, Dennison D, Shelton CD, Sunde B, Parish T.
    mSphere; 2020 Oct 14; 5(5):. PubMed ID: 33055263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct Inhibition of MmpL3 by Novel Antitubercular Compounds.
    Li W, Stevens CM, Pandya AN, Darzynkiewicz Z, Bhattarai P, Tong W, Gonzalez-Juarrero M, North EJ, Zgurskaya HI, Jackson M.
    ACS Infect Dis; 2019 Jun 14; 5(6):1001-1012. PubMed ID: 30882198
    [Abstract] [Full Text] [Related]

  • 19. MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same Target.
    Poce G, Consalvi S, Biava M.
    Mini Rev Med Chem; 2016 Jun 14; 16(16):1274-1283. PubMed ID: 26776226
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane.
    Grzegorzewicz AE, Pham H, Gundi VA, Scherman MS, North EJ, Hess T, Jones V, Gruppo V, Born SE, Korduláková J, Chavadi SS, Morisseau C, Lenaerts AJ, Lee RE, McNeil MR, Jackson M.
    Nat Chem Biol; 2012 Feb 19; 8(4):334-41. PubMed ID: 22344175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.